Article info

Download PDFPDF

Review
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies

Authors

  • Jeffrey Laurence Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Sonia Elhadad Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Jasimuddin Ahamed Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jasimuddin Ahamed; ahamedj{at}omrf.org
View Full Text

Citation

Laurence J, Elhadad S, Ahamed J
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies

Publication history

  • Received March 17, 2018
  • Revision received May 2, 2018
  • Accepted May 15, 2018
  • First published July 11, 2018.
Online issue publication 
July 11, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.